May 5, 2020 / 10:01 PM / a month ago

BRIEF-Nucana Announces Re-Opening Of Global Phase Iii Study Of Acelarin Plus Cisplatin In Patients With Biliary Tract Cancer (Nutide121)

May 5 (Reuters) - NuCana PLC:

* NUCANA ANNOUNCES RE-OPENING OF GLOBAL PHASE III STUDY OF ACELARIN PLUS CISPLATIN IN PATIENTS WITH BILIARY TRACT CANCER (NUTIDE:121)

* NUCANA PLC - RE-OPENING OF NUTIDE:121 HAS BEGUN IN CERTAIN GEOGRAPHIES, INCLUDING AUSTRALIA, CANADA, SOUTH KOREA, TAIWAN, UKRAINE AND UNITED KINGDOM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below